Outcomes of Second ‐Line Treatment After Fludarabine Cyclophosphamide and Rituximab in Patients with Chronic Lymphocytic Leukemia Outside Clinical Trials
European Journal of Haematology,Volume 0, Issue ja, -Not available-.
Source: European Journal of Haematology - Category: Hematology Authors: Erel Joffe
,
Neta Goldschmidt
,
Osnat Bairey
,
Riva Fineman
,
Rosa Ruchlemer
,
Naomi Rahimi ‐Levene
,
Lev Shvidel
,
Uri Greenbaum
,
Ariel Aviv
,
Tamar Tadmor
,
Andrea Braester
,
Ariela Arad
,
Aaron Polliack
,
Yair Herishanu Source Type: research
More News: Chronic Leukemia | Chronic Lymphocytic Leukemia | Clinical Trials | Hematology | Leukemia | Rituxan